Neutron can wait. What investors really want to see is Rocket Lab finalize its most important merger.

Rocket Lab's stock has been hammered over the past month even as its backlog swells and a transformative acquisition looms, ...

Rocket Lab sits deep in the red after a rocket test failure spooked investors, yet one top Wall Street analyst just doubled ...

Rocket Lab grew revenue 62%, but the acquisition-adjusted comparison is closer to 37.4%. Click here to read why RKLB stock is a Sell.

Rocket Lab's recent dip could be a buying opportunity ahead of the debut of its medium-lift Neutron launch vehicle.

Rocket Lab gets an upgrade after a 40%+ pullback: record Q2 revenue (+62% YoY), strong backlog, Iridium deal and better ...

Rocket Lab has some exciting things happening with its launch business, but keep your head out of the clouds.

Rocket Lab (RKLB) stock is down 8% YTD at $64.26, but Wall Street holds a Strong Buy with a $108.88 average price target ...

Rocket Lab appeared to push back the timeline for ‌the first flight of its Neutron rocket on Monday, as it now aims to get the vehicle to the launch pad in the fourth quarter rather than launching it ...

Yet Cathie Wood’s ARK Investment Management is buying. ARK purchased 504,799 Rocket Lab shares across three ETFs on Tuesday, ...